INS and diabetes mellitus: (1) Determine the incidence and causes of 30-day readmission rates for patients with a primary and secondary diagnosis of DM compared to those without DM and (2) Evaluate the impact on readmission of two specialized inpatient DM services: the Hyperglycemic Intensive Insulin Program (HIIP) and Endocrine Consults (ENDO).